Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HP Inc (HPQ) vs Tempus AI (TEM) Price & Performance

Price performance (Past 24H)

Key statistics

HP Inc vs Tempus AI — how do they compare? HP Inc trades at $30.23 (market cap $29.25B), while Tempus AI trades at $70.95 (market cap $12.58B). The key difference: HP Inc is far larger — about 2.3× Tempus AI's market cap, and HP Inc pays a 3.7% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold HP Inc for 69 Days and Tempus AI for 23 Days on average.

HPQTEM
Market Cap
$29.25B$12.58B
Volume
10,025,8067,444,569
Sector
TechnologyBroad Market / Factor
52-Week High
$35.48$99.28
52-Week Low
$18.20$41.55
Typical Hold Time
69 Days23 Days
Enterprise Value
$35.42B$13.21B
Dividend Yield
3.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HP Inc

HPQ trades at $30.2, down 6.33% on the day, amid concerns over a projected mid-single-digit PC sales decline in 2027. The stock shows strong technical momentum with a bullish moving average signal, though RSI levels are mixed. Fundamentally, HPQ maintains solid profitability with a 4.14% net margin and attractive valuation at a P/E of 12.38 and P/S of 0.51. Recent earnings beats highlight operational strength, but negative shareholder equity and high liabilities pose balance sheet risks.

The outlook is cautious; while HPQ's dividend yield of 3.82% and consistent cash flow provide income appeal, near-term headwinds from PC market softness and competitive pressures may limit upside. Analyst consensus is mixed with a $25.75 price target below current levels, suggesting limited near-term growth potential. Investors should weigh stable cash generation against cyclical industry risks and elevated debt.

Tempus AI

Tempus AI (TEM) trades at $71.46, up 1.66% with a bullish technical signal despite negative profitability metrics. The stock shows strong analyst support with 9 buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and 13 ESMO Congress presentations highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist at -$254M.

Outlook remains cautiously optimistic given strong institutional backing and AI healthcare growth potential, but profitability challenges and insider selling present near-term risks. The stock's valuation appears stretched with P/S of 8.61 and P/B of 28.27, requiring sustained revenue acceleration to justify current levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HPQ
73% Buy27% Sell
Avg holding period · 69 Days
TEM
100% Buy0% Sell
Avg holding period · 23 Days

Top news

Latest headlines on both assets

About HP Inc

HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.

Read more on HPQ →

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM →